Canada markets closed

Panbela Therapeutics, Inc. (PBLA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9800+0.0100 (+0.51%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.9700
Open1.9700
Bid1.9700 x 800
Ask1.9900 x 1100
Day's Range1.9638 - 2.0000
52 Week Range1.9120 - 8.8000
Volume5,356
Avg. Volume134,789
Market Cap26.589M
Beta (5Y Monthly)0.19
PE Ratio (TTM)N/A
EPS (TTM)-0.7450
Earnings DateNov. 08, 2021 - Nov. 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
  • Simply Wall St.

    We're Keeping An Eye On Panbela Therapeutics' (NASDAQ:PBLA) Cash Burn Rate

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...

  • GlobeNewswire

    Panbela to Present at Upcoming Investor Conferences

    MINNEAPOLIS, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that it will present at upcoming investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021 Presentation will be available on-demand beginning September 13, 2021Webcast: https://journey.ct.events/view/0f9ebd4e-a18b-4f0a-807

  • GlobeNewswire

    Panbela Provides Business Update and Reports Q2 2021 Financial Results

    MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today provided a business update and reported financial results for the quarter ended June 30, 2021. Management is hosting an earnings call today at 4:30 p.m. ET. The second quarter 2021 was marked by meaningful clinical progress. Recent Highlights Issue Notification for patent US 11,098,